HOME VULNERABILITIESCVE-2018-14786

CRITICAL

CVE-2018-14786

CWE-287Published: August 23, 2018· Updated: Jun 17, 2026

9.4

CVSS v3.1

Official Description

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.

Technical Analysis

CVE-2018-14786 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

The vulnerability requires no privileges and no user interaction, making it a prime target for automated exploitation campaigns and worm-like propagation.

A successful exploit results in full integrity compromise (data manipulation), availability disruption (denial of service), with a CVSS base score of 9.4.

From a weakness classification perspective (CWE-287): Authentication bypass vulnerabilities allow attackers to access protected resources without valid credentials.

CVSS v3.1 Vector Breakdown

Exploitability

Attack VectorNetwork

Attack ComplexityLow

Privileges Req.None

User InteractionNone

ScopeUnchanged

Impact

ConfidentialityLow

IntegrityHigh

AvailabilityHigh

CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H

Affected Vendors & Products

bd8 product(s)

alaris gs firmwarealaris gsalaris gh firmwarealaris ghalaris cc firmwarealaris ccalaris tiva firmwarealaris tiva

Source: NVD CPE · 8 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time

Offensive Security exploit database

GitHub PoC Search

Community PoC repositories

Rapid7 / Metasploit

Metasploit module search

Security advisories & exploits

Official NIST entry

CVE Program entry

External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

ADVISORYhttp://www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-for-various-alaris-plus-syringe-pumps-sold-and-in-use-outside-the-united-states

ADVISORYhttp://www.securityfocus.com/bid/105147

ADVISORYhttps://ics-cert.us-cert.gov/advisories/ICSMA-18-235-01

ADVISORYhttp://www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-for-various-alaris-plus-syringe-pumps-sold-and-in-use-outside-the-united-states

ADVISORYhttp://www.securityfocus.com/bid/105147

ADVISORYhttps://ics-cert.us-cert.gov/advisories/ICSMA-18-235-01

All References (6)

→

http://www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-for-various-alaris-plus-syringe-pumps-sold-and-in-use-outside-the-united-statesVendor Advisory

→

http://www.securityfocus.com/bid/105147Third Party Advisory · VDB Entry

→

https://ics-cert.us-cert.gov/advisories/ICSMA-18-235-01Third Party Advisory · US Government Resource

→

http://www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-for-various-alaris-plus-syringe-pumps-sold-and-in-use-outside-the-united-statesVendor Advisory

→

http://www.securityfocus.com/bid/105147Third Party Advisory · VDB Entry

→

https://ics-cert.us-cert.gov/advisories/ICSMA-18-235-01Third Party Advisory · US Government Resource

Quick Facts

CVE IDCVE-2018-14786

CVSS Score9.4 / 10

SeverityCRITICAL

WeaknessCWE-287

CISA KEVNo

Affected1 vendor(s)

PublishedAug 23, 2018

Related CVEs (CWE-287)

Recommended Actions

→Apply vendor patches immediately
→Monitor CVE-2018-14786 in threat intel feeds
→Review IDS/IPS signatures for exploitation attempts

Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.

← All Vulnerabilities·Search for CVE-2018-14786·NVD